Medicines Prescribed for Patients With Hypertension With Moderate, High and Very High Additional Risk Level
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
At least 6 prescriptions of angiotensin converting enzyme inhibitors, calcium channel blockers, beta-blockers, or angiotensin (II) antagonist medicine group, or combinations thereof issued within 14 months for hypertension patients (ODC-10 codes I10-I15) with moderate, high and very high-risk levels who are on the list.
Numerator
The number of hypertension patients with moderate, high or very high additional risk level with at least 6 prescriptions of angiotensin converting enzyme inhibitors, calcium channel blockers, beta-blockers, or angiotensin (II) antagonist medicine group, or combinations thereof issued within 14 months.
Denominator
All hypertension patients with moderate, high and very high-risk level (ODC codes I10-I15) who are on the current (reviewed) year in the list of patients with chronic illnesses who have been prescribed medication.
Exclusions
The following cases are excluded; if according to the population register, the person has left Estonia (lives abroad) or the corresponding diagnosis of chronic illness is on the treatment invoice only with the extension "0 - diagnosis unspecified".
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Medical prescription database
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Merilind et al. Pay for performance of Estonian family doctors and impact of different practice- and patient-related characteristics on a good outcome: A quantitative assessment